New Horizons GIST 2020 – GOES virtual

  The corona virus has dramatically changed our private lives and our lives as Patient Advocates worldwide. So, also NEW HORIZONS GIST 2020 was held virtually!    As many of you have already experienced: NEW HORIZONS GIST is a great opportunity where “GIST Patient Advocates / GIST Patient Group Leaders” from around the world are…

Read More

Contact

Sarcoma Patient Global Advocacy Network e.V./Assoc. – SPAGN Official registered address: Sarcoma Patient Global Advocacy Network e.V./Assoc. Mr. Markus Wartenberg Untergasse 36 D-61200 Wölfersheim / Germany E-Mail: info@sarcoma-patients.org SPAGN is registered as an association under German law (eingetragener Verein e.V.) in Friedberg/Germany – Registration-Nr. VR 2609 Tax-ID-Number: DE268771102   Please note: Sarcoma Patient Global Advocacy…

Read More

AIAA Winners 2019

SPAEN Advocacy in Action Award 2019: Winners announced For the third time SPAEN was calling again for submission of outstanding projects and initiatives for our SPAEN Advocacy in Action Award 2019. We received 12 submissions from 10 member organisations from 5 countries, so this shows the motivation among members to present their projects. These are…

Read More

Research Priorities in Bone Sarcomas

Bone sarcomas are a diverse and hard to treat group of rare cancers. People with bone sarcomas (or primary bone cancer) have high unmet medical needs, and face a range of challenges including delays to diagnosis, disparities in access to treatments and a relative lack of clinical trial and research opportunities. Take part in the first…

Read More

The SPAEN Sarcoma Research Group

Research in sarcomas needs to become more patient-centric! {loadmoduleid 124} We feel that research decision making sometimes depend on other reasons than actual needs and most important questions for patients. Therefore, we would like to work towards developing a strategy and clear direction to ultimately improve outcomes for sarcoma patients – in a collaborative effort…

Read More

SPAEN supports cancer/sarcoma patients from Ukraine with a donation of 10.000 Euro

  Wölfersheim/Germany, March 15, 2022 The current situation in Ukraine is a humanitarian catastrophe and we strongly condemn this unjustified war of aggression against Ukraine by Russian’s president Wladimir Putin. As a global organization, Sarcoma Patients EuroNet Assoc. (SPAEN) stands in solidarity with all Ukrainians. However, this situation of war is even worse for cancer…

Read More

Quality of Life and the Patient Perspective in Research

{loadposition position-18} Why should the patient perspective be assessed in cancer and sarcoma treatment? And how can measuring patient-reported outcomes improve the situation for patients? What additional information can patient-reported outcomes provide in the setting of clinical trials? Dr. Olga Husson, epidemiologist from the Netherlands Cancer Institute explains why assessing QoL is so important and…

Read More

AIAA Winners 2018

SPAEN Advocacy in Action Award 2018: Winners announced Patient advocacy ensures that people are heard, take action and ultimately improve situations, achieve changes or help to fulfil unmet medical needs. The projects that were entered for the “Sarcoma Advocacy in Action Award 2018” once again showed this impressively! All entries were fantastic and the jury…

Read More

AIAA Winners 2017

1st SPAEN Advocacy in Action Award for best projects in sarcoma patients advocacy was awarded We are very happy to have received submissions of outstanding projects and initiatives for our SPAEN Advocacy in Action Award 2017. The best projects have been awarded by a jury of 8 members consisting of patient advocates and experts. Those…

Read More

Member activities

Our member organisations are very active in their countries – we are very proud to present a selection of what is happening for sarcoma and GIST patients in the world. We thank all our organisation for their outstanding commitment! July 2019 Friends of Max Newsletter with special focus on GIST Our – Sarcoma Patients EuroNet’s…

Read More